Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk. (Q54653872)

2 June 2018

title

Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk. (English)

1 reference

2 June 2018

1 reference

2

1 reference

2 June 2018

Joerg Heil

5

1 reference

2 June 2018

Peter Sinn

7

1 reference

2 June 2018

author name string

Alina Anton

1

1 reference

2 June 2018

Gisela Kaip

3

1 reference

2 June 2018

Michelle Rath

4

1 reference

2 June 2018

Sebastian Aulmann

6

1 reference

2 June 2018

publication date

7 November 2013

1 reference

2 June 2018

Archives of Gynecology and Obstetrics

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

2 June 2018

volume

289

1 reference

2 June 2018

issue

5

1 reference

2 June 2018

page(s)

1079-1085

1 reference

2 June 2018

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends

cites work

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00404-013-3062-Y

10.1007/S00404-013-3062-Y

21 January 2018

Identifiers

DOI

1 reference

2 June 2018

release_4yrvmjl2svdxvnccg2nhvpvtye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4yrvmjl2svdxvnccg2nhvpvtye

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

2 June 2018